This website uses cookies to enhance the user experience.
S

SONOCLEAR AS917 956 146

Research
Limited company
Lybekkveien 8E 0772 OSLO, Norge
Services
/ Research

SONOCLEAR AS

sonoclear.no |

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

CEO
PK

Peter Kenneth Balmforth1975

Chairman of the board
LL

Lars Lund-Roland1956

Years since formation
8 years
since Oct 28, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
12,402,694
1 share class
Total number of shareholders
21
18 companies, 3 persons

Financials

Total operating income 2023
2,125,935
NOK
Annual total result 2023
-6,946,775
NOK
Total equity 2023
45,857,896
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
PK

Peter Kenneth Balmforth

1975

Managing Director/CEO-

Board

NameRoleShares
LL

Lars Lund-Roland

1956

Chairman-
IG

Inge Hovd Gangås

1977

Board Member-
ØE

Øivind Enger

1956

Board Member-
RB

Rune Bjerke

1969

Board Member
4.23 %
indirectly
TS

Torkild Stenbock

1972

Board Member-
HO

Hans Olav Torsen

1945

Board Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
B
BDO AS
Accountant-

Top 10 individual shareholders

NameRoleShares
JA

Jan Andreas Biti

1966

-
6.72 %
indirectly
MF

Morten Frøseth

1977

-
5.26 %
indirectly
RB

Rune Bjerke

1969

Board Member
4.23 %
indirectly
LG

Leif Gunnar Aunsmo

1942

-
3.02 %
indirectly
AA

Arnfinn Aunsmo

1966

-
2.17 %
indirectly
TM

Trond Mohn

1943

-
1.8 %
indirectly
SJ

Sven Jørund Kolstø

1988

-
1.46 %
indirectly
ET

Erlend Torsen

1977

-
1.13 %
indirectly
CF

Carl Fredrik Eide

1975

-
1.1 %
indirectly
BC

Bjørn Christian Eide

1973

-
1.1 %
indirectly
Last update: Apr 26, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
S
SINTEF VENTURE IV AS
Ordinary shares
4,019,532
32.41 %
C
COFOUNDER II AS
Ordinary shares
2,417,359
19.49 %
S
SARSIA SEED FOND II AS
Ordinary shares
2,079,111
16.76 %
S
SPAREBANK 1 SMN INVEST AS
Ordinary shares
1,467,972
11.84 %
A
AUNSMO INVEST AS
Ordinary shares
374,974
3.02 %
S
SINTEF VENTURE IV B AS
Ordinary shares
360,000
2.9 %
E
ESMAR AS
Ordinary shares
302,001
2.43 %
B
BJØRN AUNSMO AS
Ordinary shares
289,974
2.34 %
B
BARKBEKKEN AS
Ordinary shares
269,474
2.17 %
T
TORSEN TANKERS & TOWERS AS
Ordinary shares
140,000
1.13 %
T
TURTLE INVEST AS
Ordinary shares
131,000
1.06 %
O
OSKAR INVESTMENT AS
Ordinary shares
131,000
1.06 %
H
HARMONIUM INVEST AS
Ordinary shares
120,000
0.97 %
L
LEADENHALL INVEST AS
Ordinary shares
91,089
0.73 %
H
HERING AS
Ordinary shares
73,750
0.59 %
H
HALVOR CELIUS HOLDING AS
Ordinary shares
42,421
0.34 %
TS

Tormod Selbekk

1969

Ordinary shares
27,500
0.22 %
GU

Geirmund Unsgård

1948

Ordinary shares
27,111
0.22 %
E
ELAR HOLDING AS
Ordinary shares
20,588
0.17 %
AÅ

Alma Åslund

1981

Ordinary shares
15,838
0.13 %
U
UNSGÅRD-MEDTEK AS
Ordinary shares
2,000
0.02 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
2,125,935
4,253,241
230,462
Annual Total Result
-6,946,775
-11,599,922
-5,157,671
Total assets
52,166,281
46,841,007
38,702,221
Total liabilities
6,308,385
6,742,604
4,147,374
Total equity
45,857,896
40,098,403
34,554,847

P&L

Year202320222021
Total operating income
2,125,935
4,253,241
230,462
Total operating costs
8,662,801
11,577,428
6,765,315
Operating result
-6,536,867
-7,324,187
-6,534,852
Financial income/costs
-409,908
-71,211
-214,508
Profit before tax
-6,946,775
-7,395,398
-6,749,360
Total tax & extraordinary income/cost
0
4,204,524
-1,591,689
Annual Total Result
-6,946,775
-11,599,922
-5,157,671

Balance overview

Year202320222021
Total fixed assets
40,838,201
34,916,267
32,234,479
Total current assets
11,328,081
11,924,740
6,467,742
Total assets
52,166,281
46,841,007
38,702,221
Short term debt
2,375,052
2,742,604
4,147,374
Long term debt
3,933,333
4,000,000
0
Total liabilities
6,308,385
6,742,604
4,147,374
Contributed capital
45,857,896
65,860,600
48,717,122
Retained earnings
0
-25,762,197
-14,162,275
Total equity
45,857,896
40,098,403
34,554,847
Total equity and liabilities
52,166,281
46,841,007
38,702,221

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology